We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Study Supports Body Area Sensory Networks for Diagnostic Monitoring

By LabMedica International staff writers
Posted on 26 Aug 2019
The first steps have been taken on the path leading to development of a body area sensor network, which is a collection of networked sensors that can be used to remotely monitor human physiological signals.

For its application in next-generation personalized healthcare systems, stretchable on-skin sensors have to be seamlessly meshed with rigid silicon readout circuits. More...
Toward this end, investigators at Stanford University (Palo Alto, CA, USA) devleoped a body area sensory network (a bodyNET) composed of chip-free and battery-free stretchable on-skin sensor tags that were wirelessly linked to flexible readout circuits attached to clothing. This design offered a conformal skin-mimicking interface by removing all direct contacts between rigid components and the human body. Thus, this design addressed the mechanical incompatibility issue between soft on-skin devices and rigid high-performance silicon electronics.

For communications between the skin sensors and the clothing-bound receivers, the investigators introduced an unconventional radiofrequency identification technology where the wireless sensors were deliberately detuned to increase the tolerance of strain-induced changes in electronic properties. Thus, the bodyNET comprised chip-free and battery-free stretchable on-skin sensor tags, which had been screen-printed with metallic ink, that were wirelessly linked to flexible readout circuits attached to textiles.

The investigators used this prototype bodyNET to simultaneously and continuously analyse an individual’s pulse, breath, and body movement.

Ultimately, it is intended that this technology evolve into a device that would be comfortable to wear and have no batteries or rigid circuits to prevent the body sensors from stretching and contracting with the skin in response to changes in the subject’s physiology.

"We think one day it will be possible to create a full-body skin-sensor array to collect physiological data without interfering with a person's normal behavior," said senior author Dr. Zhenan Bao, professor of chemical engineering at Stanford University.

The bodyNET concept was discussed in a paper published in the August 15, 2019, online edition of the journal Nature Electronics.

Related Links:
Stanford University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.